Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

clinect nz pty limited - pentoxifylline 400mg;  ;   - modified release tablet - 400 mg - active: pentoxifylline 400mg     excipient: erythrosine hyetellose hypromellose macrogol 8000 magnesium stearate povidone purified talc   purified water   titanium dioxide - the treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).

Israel - inglês - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israel - inglês - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israel - inglês - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israel - inglês - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

new haven pharma (uk) limited - acetylsalicylic acid - prolonged-release capsule, hard - 162.5 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

galen limited - daunorubicin citrate - concentrate for soln for inf - 2 mg/ml

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 1 milligram(s) - vitamin k antagonists; warfarin

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 5 milligram(s) - vitamin k antagonists; warfarin

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 3 milligram(s) - vitamin k antagonists; warfarin